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Abstract: Metal nanoparticles have been extensively investigated for different types of pharmaceu-
tical applications. However, their use has raised some concerns about their toxicity involving the
increase of reactive oxygen species causing cellular apoptosis. Therefore, in this review we summa-
rize the most relevant toxicity mechanisms of gold, silver, copper and copper oxide nanoparticles
as well as production methods of metal nanoparticles. Parameters involved in their toxicity such
as size, surface charge and concentration are also highlighted. Moreover, a critical revision of the
literature about the strategies used to reduce the toxicity of this type of nanoparticles is carried
out throughout the review. Additionally, surface modifications using different coating strategies,
nanoparticles targeting and morphology modifications are deeply explained.
Keywords: metal nanoparticles; nanoparticles toxicity; reactive oxygen species; nanoparticles
functionalization
1. Introduction
Nanotechnology, the science of material manipulation at nanoscale level, is believed
to be one the most promising fields for biomedical applications. The use of nanomaterials
provides unique properties that are not observed at the macroscale level [1].
In this sense, one of the most novel and studied nanostructured systems are metal
nanoparticles (MNPs) [2]. In this nanotechnological area, the development of techniques
for the controlled synthesis of well-defined metal NPs constitutes an enormous challenge.
Metal NPs exhibit unique electronic, magnetic, catalytic and optical properties that are
different from those of bulk metals [3]. The exclusive features associated with NPs are
responsible for their multifunctional properties and developing interest for their application
in various fields such as medical and pharmaceutical industry. In these areas, drug and
gene delivery are of high interest. Moreover, certain metals have distinctive properties,
such as the antimicrobial properties of gold and silver [4].
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Several chemical and physical methods are employed to synthesize these nanoparticles
such as chemical reduction, electrochemical synthesis, laser ablation method, mechanical
milling, microwave-assisted synthesis or polyol synthesis. Depending on which one is
used for the preparation of nanoparticles, there will be differences on their morphology,
stability and physicochemical properties [5].
In this sense, one of the problems associated with metal and metal oxide NPs is their
possible toxicity [6,7]. Toxicity values are directly related to nanoparticles’ properties such
as morphology, size or zeta potential [8]. For instance, nanometric size is considered crucial
in nanomaterial toxicity due to their higher surface area leading to a greater reactivity [8].
Thus, the selection of preparation methods for metal and metal oxide NPs constitutes
a critical parameter to be considered leading to relevant physicochemical properties such as
chemical composition, size, solubility, shape or electrical properties, among others, which
may be the cause of enhanced toxicity issues to the human body that could result in adverse
effects on an organ, tissue or cellular level [9].
The study of the toxicity of metal nanoparticles have received increasing interest and
here we describe their toxicity mechanisms, which are of extreme relevance in order to
reduce cytotoxic effects in humans.
2. Preparation Methods
Two different strategies are used for the preparation of metal and metal oxide NPs,
which are bottom up or top down synthesis, depending on the starting material used [10,11].
When the method consists of starting from a bulk material and it is reduced to NPs by
different processes, it constitutes a top-down method, whereas if it starts from a single
atom or molecules to produce the final formulation it is a bottom-up method [12]. Here,
we describe the most commonly used synthesis methods for metal NPs (Table 1).
2.1. Laser Ablation
This is a top-down process of removing portions from the bulk material by irradiation
with a focused laser beam, generating vapor and plasma from target metal immersed in
a liquid medium [13]. This vapor-plasma plume with high pressure and temperature is
cooled by the surrounding liquid medium, leading to the formation of metal nanoparticles
via nucleation and growth steps (Figure 1). The most commonly used vapor lasers are
Nd:YAG (Neodymium-doped yttrium aluminum garnet) [14–16]. This synthesis method
allows a versatile design of the final NPs’ properties by modifying the parameters of the
process such as the vapor laser used, time or wavelength of laser pulse, ablation time or
liquid medium employed. If these parameters are optimized, this method has the capability
of yielding to well-dispersed and stable NPs. This is a simple technique involving an easy
experimental procedure with endless possibilities of conditions, which allows fabrication
of diverse NPs with desired functions. This technique has been used by several researchers
for the preparation of AuNPs, AgNPs or ZnONPs [17–19].
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ingly, this method does not require the use of chemical precursors and is considered 
eco-friendly. It has been used to successfully synthesize AuNPs and AgNPs with a con-
trolled size [22,23]. It was also used to synthesize a mixed metallic nanoparticles (Ag-Cu), 
(Pt-Au) that are immiscible using a combination of the metals in the electrodes [24]. 
2.3. Evaporation/Condensation 
Evaporation/condensation constitutes a synthesis method in gas phase which does 
not require the use of liquid solvents. In this method the particles are generated by 
evaporating the material at high temperatures and then decreasing the temperature to 
condense the metal vapor, forming nanoparticles. This method can be used to control the 
size of nanoparticles in an accurate manner. Some authors used this method to produce 
AgNPs with three specific diameters (namely, 50, 90 and 130 nm). The temperature used 
was 1300–1400 °C. Although AgNPs were successfully obtained, in the collection phase it 
was observed that some nanoparticles were attached to each other, forming aggregates 
[25]. 
Furthermore, other authors were able to eliminate these unwanted aggregates using 
a silica coating that can avoid flocculation and agglomeration [26].  
2.4. Mechanical Milling 
Mechanical milling constitutes a top-down process where the starting material is 
reduced to a nanostructure by mechanical mixing [27–29]. When the mill chamber, which 
is commonly a hollow cylindrical shell partially filled with grinding bodies made of 
stainless steel or ceramic materials, starts to rotate about a horizontal axis, it produces a 
rotational motion of the material placed inside this container causing ball drops from the 
top of the chamber to the bottom, generating impacts and collisions and finally leading to 
a homogeneous dispersion of NPs from the target material. The main parameters to be 
controlled which determine the properties of the final NPs are the raw material used, the 
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2.2. Spark Discharge
This is a simple process method and one of the most versatile techniques in the gas
phase [20,21]. Nanoparticles are obtained by using electrical discharges between two
electrodes separated with dielectric gas. Plasma channel between electrodes is formed
with dielectric medium breakdown. The generation of current flow is associated with high
temperatures that play an important role in removing material from the electrodes. This is
followed by a fast-cooling phase by adiabatic expansion and the nanoparticles are formed
by nucleation and growth steps, similar to the laser ablation technique. Interestingly, this
method does not require the use of chemical precursors and is considered eco-friendly. It
has been used to successfully synthesize AuNPs and AgNPs with a controlled size [22,23].
It was also used to synthesize a mixed metallic nanoparticles (Ag-Cu), (Pt-Au) that are
immiscible using a combination of the metals in the electrodes [24].
2.3. Evaporation/Condensation
Evaporation/condensation constitutes a synthesis method in gas phase which does
not require the use of liquid solvents. In this method the particles are generated by
evaporating the material at high temperatures and then decreasing the temperature to
condense the metal vapor, forming anoparticles. This method can be used to control the
size of nanoparticles in an accurate manner. Some authors used this meth d to produce
AgNPs with thr e specific diameters (namely, 50, 90 and 130 nm). The t mperature used
as 13 0–14 0 ◦C. Although AgNPs were successfully obtained, in the collection phase it
as observed that so e nanoparticles were a tached to each other, r i g r ates [25].
Furthermore, other authors were able to eliminate these unwanted aggregates using a
silica coating that can avoid flocculation and agglomeration [26].
2.4. Mechanical Milling
Mechanical milling constitutes a top-down process where the starting material is
reduced to a nanostructure by m chanical mixing [27–29]. When the mill chamber, which is
commonly a hollow ylindrical s ell p rtially filled with grinding bodies ade of stainless
teel or ceramic materials, starts to rotate about a horizontal axis, it pr uces rotational
motion of the material placed in ide this container c using ball drops from the top of
the chamber to the bottom, generating impacts a d collisions and finally leading to a
homogeneous dispersion of NPs from the target material. The main parameters to be
controlled which determine the properties of the final NPs are the raw material used, the
size of grinding balls, the degree of filling, the rotation speed and the temperature of the
process [27].
This synthesis method allows working at low temperatures, this having the advantage
of avoiding degradation of thermolabile materials. Moreover, it does not use organic
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solvents and it is also convenient in order to be employed for large scale production [30].
The main disadvantages to be overcome are the undesired pollution which comes from the
milling media and the difficulty of preparing NPs of a small size range [27].
2.5. Electrochemical Synthesis
In the electrochemical synthesis method, it is necessary to use a bulk solution con-
taining metal salts. This technique consists of the electrodeposition of the metal NPs in
the substrate surface [31,32]. The main parameters to control in the process are the elec-
trode potential and current density, which will affect the deposition kinetics as well as the
nucleation and crystal growth. These parameters are crucial to controlling the properties
and morphology of metal NPs. Moreover, nucleation and growth process are important to
control in order to synthetize metal NPs with a suitable dispersion [33,34].
2.6. Chemical Reduction Method
Chemical reduction constitutes one of the most popular and used synthesis methods,
since it is a simple and low-cost method to obtain controlled particle size with low size
dispersion. In this process, a bulk solution containing the metal precursor is used and a
surfactant and reducing agent are added during the chemical reaction [35]. This process
consists of the reduction of the metal cations contained within the metal salts to form metal
atoms [36]. The collisions and aggregations between the formed metal atoms and cations
result in the formation of clusters. The nucleation is continuously growing to a critical size
when the NPs are stabilized. The rate of nucleation growth is crucial to control the shape
and size of metal NPs. This rate can be modified using different surfactants, reducing
agents or metal precursors, as well as the pH and the temperature at which the reaction
is carried out. The metal precursors are usually salts containing the target metal atom.
For instance, AgNPs are usually produced using AgNO3 as a precursor. A surfactant is
used in this process to prevent NP aggregation and to disperse them within the solution.
Additionally, NaBH4 is widely used as a reducing agent. The use of amine-boranes as
reducing agents is being increased [37,38], both for their capability to be used also as
stabilizing agents and because they do not require solvent addition [39,40].
One other kind of chemical reduction process is employing polyols that have emerged
as a very useful reducing agent. In this process, polyols also act as a solvent of the metal
salt precursor. Polyols have some advantages such as their capacity to coordinate particle
surfaces, which prevents or minimizes coalescence, its high boiling point and its high
viscosity due to the presence of several hydroxyl groups, which allows working at high
temperatures and favors the control of particle growth [41]. Several metal NPs have been
successfully obtained in the last few years using the polyol synthesis method [42–45].
2.7. Microwave-Assisted Synthesis
In the last several years, the microwave-assisted synthesis method has received in-
creasing interest due to its effective use of dielectric heating that has demonstrated to
reduce the time of reaction and the side reactions, which can lead to enhanced chemical
yields and reproducibility of the process. Compared to conventional heat conduction
methods, the microwave is more efficient in terms of temperature homogeneity and energy
used [46]. This technique is usually combined with the previously mentioned methods.
For instance, polyol synthesis can be improved with microwave heating [47,48].
2.8. Green-Synthesis
Nowadays, the development of metal NPs using green-synthesis methods is being
intensely studied [49–53]. Application of green chemistry can reduce the use of hazardous
solvents or other toxic compounds, improve the energetic efficiency of reactions and
processes, and minimize safety issues. The main strategies are based on plant mediated
synthesis where a metal salt precursor is obtained from plants. Plant extracts are also rich
on alkaloids, flavonoids, terpenoids or phenolic acids that can reduce metallic ions to metal
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atoms leading to NP formation [54–56]. One of the main advantages of this method is the
reduction of human and environmental toxicity, since they are more biocompatible and
less harmful for health, and the production methods are eco-friendly, using organic natural
sources and reducing energy consumption [49].
Table 1. Production methods of metal nanoparticles [12,57].
Synthesis Method Advantages Disadvantages
Laser ablation
Simple and effective
Easy to modify nanoparticles
properties by changing synthesis
parameters
The laser path can be blocked by
the portions of material released
from the surface, causing









No solvents used High energy required







Simple, fast and inexpensive
method
Control of size and morphology of
nanoparticles
Impurities from liquid media
Chemical reduction
method Simple and effective
Impurities from reaction
Toxicity issues of reactive agents
Microwave-assisted
synthesis








Reduction of energy consumption
Use of natural sources
Less effective than other methods
3. Toxicity Mechanisms of Metal Nanoparticles
A large number of drug delivery formulations based on metal NPs are successfully
applied in biomedicine, clinics, cosmetics and pharmaceutical industry. While the inclusion
of nanomaterials in several products can enhance their performance, on the other hand,
there is growing evidence that the small particle size may also induce undesired side effects.
The reduced size at the nanoscale level creates complex physicochemical interactions when
exposed to a physiological environment [58].
Consequently, despite some unique advantages associated specifically to metal NPs,
potential toxic effects should be considered, both for human administration and for the
environment after their application [36].
The key to understand the toxicity of metal NPs is that their small size allows them
to show an increased penetration rate but also to cause alterations in the cellular redox
balance leading to increased production of reactive oxygen species (ROS) and thus causing
abnormal cellular functionality, leading to cytotoxic effects (Figure 2) [59,60]. Uncontrolled
generation of ROS causes harmful effects on cellular structures such as proteins, lipids
and nucleic acids, and some evidence shows that this can also be responsible for the pro-
gression of several diseases [61–63]. The interaction between lipids and reactive species
can cause lipid peroxidation. This process is a chain reaction created by free radicals to
form lipid hydroperoxides. The accumulation of hydroperoxides and their subsequent
decomposition to alkoxyl and peroxyl radicals accelerates the peroxidation of polyunsatu-
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rated fatty acids leading to oxidative damage to cell membranes [64]. It has been shown
that the consequences of lipid peroxidation include the decrease of lipid fluidity and a
subsequent alteration of its permeability and integrity, leading to a functional loss of cell
membranes [65].
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It has also been shown that ROS can also induce DNA damage by several oxida-
tive reactions with DNA bases leading to mutations. Oxidative DNA damage has been
demonstrated to play an important role in the initiation and development of cancer [66,67].
Mitochondria also play and important role in cell damage. The overproduction of ROS
cause mitochondrial release of apoptogenic signaling molecules inducing caspase cascade
responsible for cell death [68,69]. An additional mitochondrial-independent pathway is
also induced by ROS by other signaling molecules such as Caspase 8 or Fas protein.
Thus, to ensure the safe development of NP-containing products, scientific knowledge
on potential hazards posed by these nanostructured systems needs to be deepened hand-
in-hand with the progress in nanotechnological industry. Reaching this ultimate goal
will enable us to avoid, at least, synthesizing potential toxic engineered nanomaterials
for commercial use. Moreover, understanding the interaction mechanisms of NPs with
cells and their consequences is the first defense in hazard prevention also regarding to
accidentally produced NPs due to human activities or derived from natural causes.
3.1. Silver Nanoparticles
Silver NPs (AgNPs) are being increasingly used in many different products. They
are well known for their antibacterial activity. However, the potential toxicity of AgNPs
constitutes a great concern [70–72].
AgNPs can induce toxicity mainly by two different pathways. The first one is the
release of a Ag+ ions, which are toxic in high concentrations [73,74]. The second one
is derived from the nanometric size of AgNPs. These are able to interact with proteins,
nucleic acids and carbohydrates of the biological system, modifying their surface properties.
However, these surface changes play an important role in the interaction of NPs with cell
surface receptors, facilitating the entrance of the NPs via endocytosis. AgNPs’ uptake
can also be influenced by their size, shape and concentration [75]. In this area, AgNPs’
concentration-dependent toxicity has been studied in a zebrafish model [76]. In this study,
different concentrations (5, 10, 25, 50 and 100 µg/L) of AgNPs were added to zebrafish
embryos and incubated for 72 h at 28.5 ◦C. The mortality of zebrafish embryos increased
proportionally to AgNPs’ concentration. The calculated LC50 was stablished between
25–50 µg/L and at 100 µg/L only 15–30% were alive. Hearth rate and hatching rate were
also induced by AgNP in a dose-dependent manner. In a preclinical study the skin toxicity
of AgNPs was evaluated [77]. Three different concentrations of AgNPs (0.34, 3.4 and
34 µg/mL) were topically administered to a pig animal model. Significant differences of
focal inflammations and edemas between 0.34 and 34 µg/mL were observed, being the
Toxics 2021, 9, 195 8 of 20
latter the concentration with higher toxic effects [77]. AgNPs can permeate cell membranes
and produce higher levels of intracellular Ag+, causing cytotoxic and genotoxic effects.
The cytotoxic effects of AgNPs have mostly been characterized in terms of oxidative stress,
DNA damage and modulation of cytokine production. The cellular uptake of AgNPs can
stimulate the production of radical oxygen species (ROS), resulting in oxidative stress. ROS
can induce cell death either by apoptosis or necrosis [78–80].
Regarding genotoxicity, the increased generation of ROS produced by AgNPs can
cause DNA damage by decreasing ATP production, which is associated with mitochondrial
damage, impairing energy-dependent DNA repair mechanisms [81]. Direct DNA damage
by Ag+ or by Ag NPs themselves have also been reported [82,83].
Moreover, in vitro studies have shown the toxic effects of AgNPs in different cells
lines. AgNPs have been exposed to murine macrophage cell RAW 264.7 [84], where an
increase of cytotoxicity caused by citrate coated 20 nm AgNPs compared with those of
110 nm was observed by causing a more intense acute pulmonary inflammation. The
results also showed a reduction of toxicity when AgNPs were coated with PVP avoiding
Ag+ complexation.
Other studies have also demonstrated size-dependent toxicity of AgNPs. In this sense,
Gliga and colleagues used bronchial epithelial cells (BEAS-2B) that were exposed to AgNPs
of different average sizes [85]. The results showed a higher cytotoxicity in the smallest size
of AgNPs (10 nm) with higher release of free silver ions [86]. Other studies using alveolar
epithelial cells (A549) and human epidermal keratocytes (HEKs) revealed a clear influence
of the surface properties of AgNPs, the AgNPs coated with carbon being less cytotoxic [87].
Finally, in an interesting study, human mesenchymal cells exposed to AgNPs show a
release of interleukins 6 and 8 and vascular endothelial growth factor (VEGF) secretion.
Moreover, DNA damage was evaluated with a COMET assay and chromosomal aberration
test, showing significant damage after 1 h and a concentration-dependent toxicity [88].
These results showed that the toxicity of AgNPs strongly depends on size and shape,
surface properties and concentration.
3.2. Gold Nanoparticles
Interest in gold nanoparticles (AuNPs) has increased due to their ease of synthesis
and their unique properties with a potential use in drug delivery [89,90] and in biological
imaging, which makes them attractive tools for cancer detection and therapy [91,92].
It has been found that the toxicity of AuNPs is closely related to their physicochemical
parameters that can influence their biological activity and cellular interactions.
Depending on the synthesis method or functionalization processes, an AuNP’s surface
can also be modified, being a crucial factor for toxicity due to the fact that different molecu-
lar interaction can occur. For instance, Goodman and co-workers found that modifying the
surface charge of AuNPs caused different levels of toxicity. They determined that cationic
AuNPs were moderately toxic, whereas anionic AuNPs showed no evidence of toxicity [93].
In contrast, in the study developed by Schaeublin and colleagues [94], both anionic and
cationic AuNPs caused toxicity, observing in the anionic AuNPs even higher toxicity. This
can be explained by the different synthesis methods, using different chemical groups to
modulate the surface charge. Moreover, other studies can be found demonstrating the
influence of the ligand agent used to modify AuNPs surface [95].
Currently there are very few published studies that examine the risks and side effects
of AuNPs, but they indicate that the cause of toxicity can be related to ROS production.
In this sense, Jia et al. found out that when the concentration of AuNPs is increased, the
NO-released levels were also elevated thus highlighting that a dose-dependent response in
reactive nitrogen species (RNS) exists between RNS and AuNPs [96]. This can be due to the
fact that NO can react with superoxide producing peroxynitrite species which can interact
with DNA, proteins or lipids via oxidative reactions. This reaction may cause oxidative
injury, leading to necroptosis or apoptosis [97]. Li et al. also demonstrated that there is a
clear evidence that the presence of AuNPs induce oxidative DNA damage [98]. Moreover,
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other authors also evidence the direct relationship between AuNPs and ROS concluding
that at high doses such as 40–50 µg of AuNPs, a significant ROS induction was detected.
Moreover, the latter study also showed that ROS generation can be related to production
of TNF-α that could be involved in cell death [99]. Further studies showed that the
LC50, calculated with Daphnia Magna model, ranged from 65 mg/L to 75 mg/L showing
a significance reduction with bimetallic Ag-Au NPs (15 mg/L) [100]. It has also been
found that AuNPs can induce autophagy process. Autophagy is a lysosome-dependent
degradative pathway that plays an major role in maintaining cellular homeostasis. Ma et al.
demonstrated that AuNPs can cause autophagosome accumulation by blocking autophagic
flux in a size-dependent manner, showing that 50 nm AuNPs increase the autophagosome
accumulation compared to 25 nm and 10 nm [101]. In addition, surface functionalization of
AuNPs constitutes a critical aspect to induce autophagy. This has been demonstrated with
CTAB-coated Au-nanorods, which possessed higher toxicity than Au-nanorods coated with
PSS and PDDAC [102]. This could be interesting for future biomedical applications since
recently some researchers have focused on autophagy mechanism as a possible treatment
for cancer [103,104].
3.3. Copper/Copper Oxide Nanoparticles
As previously mentioned for Au and AgNPs, ROS and RNS production also play an
important role in copper/copper oxide nanoparticles (CuNPs/CuONPs) toxicity [105–107].
In this area, Sarkar et al. observed that CuNPs exposure induced the production of ROS
and NO, which decreases the activity of antioxidant enzymes [108]. A TUNEL assay was
performed to confirm that higher levels of ROS also induce a cascade pathway leading
to apoptotic cell death in kidney tissue. This study also demonstrated that the presence
of CuNPs induces the release of cytochrome C in the cytosol due to the reduction in mi-
tochondrial membrane potential caused by the alteration of the Bcl/Bax ratio. The Bcl
family controls the intrinsic apoptotic pathway. The Bcl2 protein has an antiapoptotic effect,
contrary to Bax protein which has pro-apoptotic activity, so the Bcl2/Bax ratio is a key
factor to control the caspase cascade leading to a programed cell death [109]. The loss of
mitochondrial membrane potential induces the loss of level expressions in Caspases 9 and 3
causing cell death via mitochondria-dependent pathway. In addition, the extrinsic pathway
where the exposure of CuNPs produced an increase in the cellular levels of Fas protein, cas-
pase 8 and tBID was studied. It suggests the involvement of a mitochondrial-independent
pathway. As such, this study suggests the involvement of two apoptotic pathways to
control cell death [108]. Those results are in agreement with other studies investigating the
induction of oxidative stress in nanotoxicity. Specifically, Assadian et al. found that the
generation of ROS results in the alteration levels of glutathione and peroxidase damage
to membrane lipids which can cause cell death in human lymphocytes [110]. Moreover, it
has also been described that CuNPs induce apoptosis in HepG2 cells via mitochondrial
pathway, evidenced by the modification of Bcl2/Bax ratio originating the caspases 9 and
3 activation [111]. Moreover, it has been reported that the LD50 of CuNPs (23.5 nm) is
around 413 mg/Kg. However, this is still controversial. In this area, an interesting study
exposed male rats to several CuNPs concentrations (5, 10 and 100 mg/Kg) and after 2, 7
and 14 days the histological changes and hepatic enzymes level were evaluated. The results
show that all concentrations induced toxicity as well as modifications in histopathology of
liver and lung tissues [112]. In a different study, CuNPs concentrations ranged between 50
and 200 mg/Kg/day were also applied to rats for 5 days. In this case, the results showed
lower hepatotoxicity with 50 and 100 mg/Kg/day than at doses of 200 mg/Kg/day [113].
3.4. Zinc/Zinc Oxide Nanoparticles
Zinc and zinc oxide nanoparticles (ZnNPs, ZnONPs) can enter the cell by two differ-
ent pathways: diffusion of free Zn2+ ions dissolved in extracellular medium and direct
internalization of ZnNPs [114]. The dissolution of ZnNPs to release Zn2+ ions has a strong
dependence on pH of the medium. The presence of other components in the medium, the
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UV radiation, the concentration and NPs size are other factors that can have an influence
in the release of Zn2+ [115].
ZnO + 2NaOH→ Na2ZnO2 + H2O
ZnO + 2HCl→ ZnCl2 + H2O
ZnCl2 → Zn2+ + 2Cl−
The internalization of ZnNPs is carried out via endocytosis mediated by membrane re-
ceptor or particular endocytic pathways such as the Claritin-dependent pathway, caveolae-
independent pathway or caveoloae-dependent pathway [116].
Free Zn2+ generated from ZnNPs has an important effect on toxicity. Studies investi-
gating ZnNPs’ toxicity indicate that a correlation between the concentration of free ions
and cell viability exists. Moreover, in this case the consequence is that LDH is released,
causing cell membrane damage [117].
Furthermore, the internalized ZnNPs induce the generation of ROS [118], leading to
cytokines prompting inflammation that can result in cell death [119].
The toxicity effects of 20 nm ZnONPs were investigated at different doses (5, 50, 100,
300, 1000 and 2000 mg/Kg) administered to rats by oral route [120]. Surprisingly, lower
doses showed higher toxicity effects. This might be caused by less agglomeration of ZnO
NPs at lower doses that allows them to penetrate into the cells easily [120]. However,
future research needs to be focused on lower doses in order to determine the LD50 of Zn
and ZnONPs.
3.5. Iron Oxide Nanoparticles
The toxicity of iron oxide nanoparticles (FeONPs) is closely related to their size, charac-
teristics of the surface, shape and concentration. Fe2O3 (maghemite) and Fe3O4 (magnetite)
are the most widely used iron materials for NPs synthesis. However, maghemite is pre-
ferred to be used since Fe3+ can already be found in the human body and is less likely to
cause toxic effects. They differ in the oxidation state which modifies their physicochemical
properties [121]. The release of iron in cellular medium can produce free radicals by Fenton
reaction, in which the combination of iron ions and hydrogen peroxide (H2O2) generates
hydroxyl radicals [122]. The accumulation of hydroxyl radicals can induce lipid peroxida-
tion processes which leads to ferroptosis causing cell death. Recently, iron-based NPs have
been studied in cancer therapy due to this phenomenon [123].
Moreover, FeONPs are used as MRI contrast agents at a concentration of 0.56 mg/Kg.
Furthermore, concentration-dependent toxicity of FeONPs has been also studied in vitro us-
ing murine macrophage cell line J774 at concentrations ranging between 25 and 500 µg/L [124].
Cell viability at 25 µg/L was 95–100% and decreased up to 55–65% at 500 µg/L. Apoptosis
index at 25 µg/L was 1.9 and increased up to 26.8 at 500 µg/L [124].
Another in vitro cellular study showed that FeONPs were able to cause cellular mem-
brane damage in erythrocytes, altering their mechanical properties and inducing oxidative
stress [125]. The main sources of ROS production are direct generation from their surface,
via FeONPs disintegration, from organelle dysfunction or some induction of cell signaling
pathways [126–128].
Another study showed that internalized FeONPs can induce ROS production in a
dose and time-dependent manner. As concentration of FeONPs increased, higher ROS
formation was also observed. No further increase in ROS generation was observed at
higher concentrations (2 mg/mL, 3 mg/mL), which may be due to saturation in the cellular
surface, blocking the uptake of additional FeONPs. Therefore, cellular uptake was at
maximum during the first 3 h of exposure, and no increase was found after 4 h, probably
due to saturation of the cellular entrance mechanisms [129].
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4. Strategies to Reduce Metal Nanoparticles Toxicity
In spite of their great potential for pharmacological use, metal NPs are associated with
toxicity issues. The main toxicity problems are closely linked with the release of free ions,
their reactivity with biological molecules, tendency to agglomerate, or oxidative damage.
Toxicity can be modified depending on the characteristics of metal NPs, such as size
and shape, surface charge or composition, which, at the same time, are closely related
to the synthesis method. The development and optimization of synthetic routes are
crucial to reduce or eliminate the toxicity issue. Moreover, reduction toxicity strategies are
summarized in Table 2.
4.1. Surface Functionalization
In order to stabilize metal NPs, in addition to enhancing their uptake and biocompati-
bility, organic functional groups have been used to modify NPs’ surfaces.
One of the most commonly used organic groups for functionalization is polyethylene
glycol (PEG), which produces a steric barrier preventing the attachment of phagocytes
and shielding the surface from aggregation and opsonization, leading to a prolonged time
on the systemic circulation (Figure 3) [8,130,131]. These neutral, flexible, and hydrophilic
PEG chains help in minimizing adverse immunological effects [132]. PEG weights range
from hundreds to several thousands of Daltons. Additionally, low-weight PEGs are highly
soluble in water but PEG solubility decreases with increasing molecular weight [133]. In
general terms, to achieve the necessary stealth properties, the most suitable molecular
weight of PEG has been reported between 1500–5000 Da [133]. However, with ZnO, TiO2
and Cu2O it was observed that low-molecular-weight PEG has a smaller steric effect than
long-chain PEGs [133].
Moreover, the terminal OH group of PEG may be selectively oxidized to functionalize
PEG with various terminal end groups or to attach large ligands [133]. The use of PEG
with additional amino (PEG-NH2) and thiol (PEG-SH) groups has been advocated as
useful strategy [134]. AuNPs with average size ranged between of 1.5 and 5.9 nm have
been produced and functionalized with PEG-SH and also with PEG-NH2 groups. These
NPs show better physical and biological properties for drug delivery applications and no
cytotoxic effects were observed in AuNPs-PEG-SH, in contrast with AuNPs-PEG/NH2
and AuNPs-PEG [134]. Using AuNPs, it has also been reported that the spacer length of
the PEG (the link between the NP surface and the PEG) also plays a major role, especially
when fluorescent tags are also attached to the NPs surface [133].
In this area, a significant reduction of cytotoxicity was also observed in ZnNPs func-
tionalized with PEG. The use of PEG reduced the formation of the protein corona, leading
to lower toxicity compared to uncoated ZnNPs [135]. Moreover, Wuelfing et al. reported
that a monolayer thiol PEGylation of surface metallic AuNPs with octaedral shape by
CH3O–PEG–SH significantly improved their dispersion stability in aqueous milieu due to
the steric repulsion effects of ethered PEG strands [132,136].
In addition, several potential safety concerns have been recently raised from the
repeated use of PEG-related products since PEG is not biodegradable. Usually, lower
molecular weight PEGs are preferable for biomedical applications since high molecular
weight PEG can be acccumulated on some tissues. Moreover, under exogenous stress
conditions such as heat, radiation or mechanical forces, PEG showed degradation [132].
Furthermore, PEG’s potential synthetic impurities such as 1,4-dioxane, formaldehyde and
cyclic dimer of the ethylene oxide emphasize the usage of a highly technical grade of PEG
for biomedical applications [132].
Surface charge is another relevant factor to consider, since it has influence in the
NPs’ blood stream solubility and interaction with biological molecules and cell mem-
branes. Therefore, a really interesting computational study showed the effects of AuNPs
functionalization with carboxylic groups. These may to be spontaneously protonated on
the AuNP’s surface, leading to a more controlled and less disruptive interaction with
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cell membranes [137]. However, in vivo results will be necessary in order to corroborate
this result.
4.2. Antibody Functionalization
Antibody-functionalized metal NPs constitute a novel and promising strategy to
reduce toxicity by enhancing targeting and effectiveness of drug delivery. In this area, an
interesting study using ranibizumab, showed significant improvements in reduction of
toxicity in hybrid Au/Fe3O4NPs. Ranibizumab-coated Au/Fe3O4NPs were successfully
prepared with a non-covalent binding synthesis technique. The MTT assay showed no
toxicity of Ranibizumab-coated Au/Fe3O4NPs [138].
In this area, the use of metal NPs coated with antibodies has a huge potential for
cancer treatment, providing better targeting and control of the drug release in specific
tumor areas [139].
For instance, AuNPs were conjugated with cetuximab antibody by Li and coworkers
to enhance the specificity of AuNPs to human cancer cells through the conjugation to
tumor-specific ligands such as EGFR, which is expected to be a promising candidate for
cancer therapy [140]. They use the combination of AuNPs charged with H+ particles
functionalized with antibodies for radiosensitizing therapy. The results showed a good
binding capcity between cetuximab and and EGFR in a concentration-dependent manner
leading to a rapid and efficient cell uptake. An enhancement of the effect by proton
radiation was observed compared with non-targeted AuNPs [141].
4.3. Coating Modification
The primary purpose of coating modifications is to reduce metal ion release and
agglomerations and avoid oxidation processes.
Within this field, silica-based coatings are the most frequently used. In this sense,
ZnNPs have been prepared by Chia et al and coated with silica to prevent the release
of Zn+2. The results showed that the presence of the silica coating effectively reduced
cytotoxicity in addition to retaining the antimicrobial properties of ZnNPs [142]. Another
study carried out in vitro using FeONPs coated with thin silica shell in A549 and HeLa cells
showed a significant reduction of ROS production in Fe3O4/SiO2 compared to uncoated
NPs, leading to a decrease of cytotoxicity [143]. Moreover, a reduction of DNA damage
was also observed [143]. Other authors also found that the use of silica coating in AgNPs
effectively reduced their toxicity. SiO2 was demonstrated to prevent the direct interaction
of cells with AgNP surfaces and the liberation of Ag2+ ions [144,145].
Chitosan, a natural alkalyne polysaccharide with good biocompatibility and biodegrad-
ability, constitutes a widely used compound for NPs coating. This long chain carbohydrate
can avoid surface oxidation and control the disintegration of metal NPs, reducing their
potential toxicity. Chitosan coating was shown to effectively reduce toxicity of CuNPs in
an in vitro study using human A549 cells. This toxicity reduction appears to be linked to
decreased ROS generation, suggesting that chitosan coating enhances the release control of
copper ions [146]. In a different study, chitosan-coated AuNPs were synthesized to evaluate
the uptake, cytotoxicity and immunological responses. The results showed that chitosan
can modullate the interaction between AuNPs and proteins in cellular culture medium,
modifying cellular responses. The human monocytic cell line was used to assess the uptake
and cytotoxicity of chitosan coated AuNPs. Cellular internalization capacity of chitosan
coated AuNPs has been compared with citrated funtionalized AuNPs. The positive charge
of chitosan has been shown to associate with negatively charged lipid bilayers leading to
a greater and faster internalization compared with anionic coatings. Cationic surface has
also shown to enhance the interaction with serum proteins since most of them are anionic
improving phyisicochemical properties of AuNPs. However, it has to be taken into account
the observed cellular inflammatory responses induced by chitosan due to the enhanced
particle interaction [146,147]. Figure 3 summarizes the surface and coating modification
strategies of metal and metal oxide nanoparticles.
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The average size of synthesized metal NPs ranges from 1 to 100 nm. This parameter
confers different properties compared to the bulk material form. The higher surface area
enhances their reactivity, with higher number of molecules interaction in cellular system.
Moreover, the reduction of size also allows for enhancing the cellular uptake of NPs,
leading to a higher concentration inside the cell [148]. Thus, size plays an important role in
determining the toxicity of nanomaterials. Some studies demonstrate the size-dependent
toxicity of metal nanoparticles. For instance, a citotoxicity study was carried out exposing
different AgNP sizes (20 nm, 80 nm, 113 nm) to RAW 264.7 and L929 cells. The results
showed significant differences in ROS production and extracellular LDH activity, being
higher in the case of the smallest AgNPs [149].
However, not all studies show higher uptake and toxicity with the smallest NPs. A
study developed with AuNPs was performed, exposing different AuNPs sizes (namely, 14,
30, 50, 74 and 100 nm) to cells. Results showed that the greater uptake was obtained by
50 nm AuNPs with no significant difference in toxicity among the populations assesed [150].
On the other hand, an interesting in vivo study showed highest adverse effects in mice of
AuNPs with sizes ranging from 8 to 37 nm, while nanoparticles of 3, 5, 50 and 100 nm did
not show any cytotoxic effects [151].
Although the majority of the evidence points out a trend towards increased toxicity
related with smaller NP size, further studies will be necessary. However, it is sure that
size-dependent toxicity has to be taken into account when developing metal and metal
oxide NPs in order to reduce their possible side effects.
4.4.2. Shape
Shape is also a critical factor contributing to toxic effects. Different NP shapes have
influence in the interaction with biological molecules and to cross through biological
barriers. Metal NPs can be synthesized in many different shapes such as spheres, triangles,
rods, stars and cubic prisms (Figure 4) [149,152].
Nanospheres, nanostars and nanorods based on AuNPs have been synthesized to
investigate the influence of shape [153]. Even though the results showed the highest
uptake with the nanospherical shape and the lowest with nanostars, the cytotoxicity of
nanospheres was also the lowest, suggesting that higher uptake does not always induce
higher toxicity [153]. Recently, it has been demonstrated that crystal orientation of metal
nanocrystals has a considerable influence in cytotoxicity [154]. The results of this study
showed that 100 Pd nanocrystals show less toxicity than 111 Pd nanocrystals. These results
seem to be related to the stronger oxygen-binding capacity of 100 Pd nanocrystals compared
to 111, resulting in less hydroxyl radical generation and reducing the oxidative damage.
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In summary, metal and metal oxide NPs show unique properties that allow them to
be a promising tool for the therapeutic treatment of several diseases. Since the use of these
nanosystems are of increasing interest, more experts are focusing on the investigation of
their abilities to be used for biomedical applications. However, toxicity mechanisms need
to be deeply understood in order to be able to reduce their risks. In general terms, the most
critical issues are the release of free metal ions, the intracellular uptake and the oxidative
reactions leading to inflammatory responses.
The optimization of synthesis methods and the reduction of nanotoxicity are inter-
locking goals that need to be pursued in parallel, since it is clear that the morphology and
physicochemical properties of NPs are closely linked with toxicity. Importantly, metals
are not biodegradable materials and it is of crucial relevance to find the most adequate
surface functionalization in order to increase their biocompatibility and improve their
targeting, trying to avoid the generation of harmful species in body systemic circulation.
Optimization of size and shape combined with functionalitzation of NPs by surface coating
or ligands such as antibodies attached to their surface consitutes a successful tool to reduce
the toxicity of metal NPs.
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